Aurobindo Pharma has informed that it enclosed a copy of the Press Release on 27th August 2021 in connection with USFDA approval received by Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company, for Cyclophosphamide Injection.
The above information is a part of company’s filings submitted to BSE.